Tenvie Therapeutics Funding: $200M Raised, Series A (2025)

Tenvie Therapeutics funding overview

Tenvie Therapeutics is a Biotech company based in South San Francisco. Tenvie Therapeutics has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for Tenvie Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include ARCH Venture Partners, F-Prime Capital, Mubadala Capital, Bain Capital Life Sciences, Digitalis Ventures, Forbion and 4 others. 10 distinct backers are named across the disclosed rounds.

Tenvie Therapeutics at a glance

Total raised: $200M
Latest round: Series A
Latest round date: January 2025
Industry: Biotech
Headquarters: South San Francisco
Notable investors: ARCH Venture Partners, F-Prime Capital, Mubadala Capital, Bain Capital Life Sciences, Digitalis Ventures, Forbion, Pivotal BioVenture Partners, Polaris Partners

Frequently asked about Tenvie Therapeutics funding

How much has Tenvie Therapeutics raised?: Tenvie Therapeutics has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Tenvie Therapeutics?: ARCH Venture Partners, F-Prime Capital, Mubadala Capital, Bain Capital Life Sciences, Digitalis Ventures, Forbion are named among the investors backing Tenvie Therapeutics.
What was the latest Tenvie Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2025.
Where is Tenvie Therapeutics based?: Tenvie Therapeutics is based in South San Francisco.
What sector does Tenvie Therapeutics operate in?: Tenvie Therapeutics is tracked under Biotech from South San Francisco, with $200M in disclosed funding.
When did Tenvie Therapeutics last raise?: The last disclosed Tenvie Therapeutics round closed in January 2025 at Series A.

Tenvie Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in South San Francisco below to benchmark round size and investor mix.

Tenvie Therapeutics Funding: $200M Raised, Series A (2025)

Tenvie Therapeutics funding overview

Tenvie Therapeutics at a glance

Frequently asked about Tenvie Therapeutics funding

Companies related to Tenvie Therapeutics (40)

Browse related funding lists (7)